LENZ Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Net Income	-124.65	-101.05	-70.76	-68.37	-0.11
Depreciation & Amortization	6.7	8.35	2.19	0.12	0
Share-Based Compensation	10.57	13.53	7.87	0.18	0
Other Operating Activities	17.37	-8.81	7.84	59.35	0.09
Operating Cash Flow	-90.01	-87.98	-52.85	-8.72	-0.02
Capital Expenditures	-8.95	-6.59	-5.74	-1.55	0
Change in Investments	235.3	-235.27	0	0	0
Investing Cash Flow	226.35	-241.86	-5.74	-1.55	0
Share Issuance / Repurchase	0.19	0.6	251.95	0.26	0
Debt Issued / Paid	0	0	0	5	0
Other Financing Activities	-	-	165.52	24.82	-
Financing Cash Flow	0.19	0.6	417.47	30.08	0
Net Cash Flow	136.53	-329.25	358.88	19.81	-0.02
Free Cash Flow	-98.96	-94.57	-58.59	-10.27	-0.02
Free Cash Flow Per Share	-12.15	-12.06	-14.18	-31.46	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).